Vanguard Group Inc Incyte Corp Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Incyte Corp stock. As of the latest transaction made, Vanguard Group Inc holds 19,951,623 shares of INCY stock, worth $2.08 Billion. This represents 0.03% of its overall portfolio holdings.

Number of Shares

19,951,623

Previous 20,135,393 0.91%

Holding current value

$2.08 Billion

Previous $1.37 Billion 23.4%

% of portfolio

0.03%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$67.27 - $86.96 $12.4 Million - $16 Million	-183,770 Reduced 0.91%	19,951,623 $1.69 Billion
Q2 2025 Aug 11, 2025	BUY	$55.17 - $71.22 $7.59 Million - $9.8 Million	137,570 Added 0.69%	20,135,393 $1.37 Billion
Q1 2025 May 09, 2025	BUY	$60.0 - $75.26 $25 Million - $31.4 Million	417,346 Added 2.13%	19,997,823 $1.21 Billion
Q4 2024 Feb 11, 2025	SELL	$65.08 - $83.38 $52.2 Million - $66.9 Million	-802,279 Reduced 3.94%	19,580,477 $1.35 Billion
Q3 2024 Nov 13, 2024	BUY	$57.33 - $68.61 $419,024 - $501,470	7,309 Added 0.04%	20,382,756 $1.35 Billion

Q2 2024 Aug 13, 2024	SELL	$51.18 - $63.75 $120 Million - $149 Million	-2,340,374 Reduced 10.3%	20,375,447 $1.24 Billion
Q1 2024 May 10, 2024	BUY	$56.55 - $66.59 $11.1 Million - $13.1 Million	196,440 Added 0.87%	22,715,821 $1.29 Billion
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $18.8 Million - $23.1 Million	359,962 Added 1.62%	22,519,381 $1.41 Billion
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $16.7 Million - $19.1 Million	289,882 Added 1.33%	22,159,419 $1.28 Billion
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $6.76 Million - $8.38 Million	110,916 Added 0.51%	21,869,537 $1.36 Billion
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $15.8 Million - $19.3 Million	224,803 Added 1.04%	21,758,621 $1.57 Billion
Q4 2022 Feb 10, 2023	BUY	$67.18 - $84.11 $20.5 Million - $25.7 Million	305,757 Added 1.44%	21,533,818 $1.73 Billion
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $15.8 Million - $19.8 Million	238,448 Added 1.14%	21,228,061 $1.41 Billion
Q2 2022 Aug 12, 2022	BUY	$66.18 - $83.18 $6.81 Million - $8.56 Million	102,857 Added 0.49%	20,989,613 $1.59 Billion
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $3.83 Million - $4.62 Million	-58,003 Reduced 0.28%	20,886,756 $1.66 Billion
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $5.98 Million - $7 Million	94,422 Added 0.45%	20,944,759 $1.54 Billion
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $26.1 Million - $31.9 Million	379,803 Added 1.86%	20,850,337 $1.43 Billion
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $1.63 Billion - $1.79 Billion	20,470,534 New	20,470,534 $1.72 Billion

Others Institutions Holding INCY

# of Institutions

797

Shares Held

205M

Call Options Held

638K

Put Options Held

635K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $23.2B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Incyte Corp Transaction History